4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-027666
Options or other derivatives
- Director acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lacey David L. Director | 2022-05-05 | Grant or award · Director Stock Option (right to buy) | +17,500 | 17,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…